Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid tumours.

The CDE of China's NMPA has granted BTD to Innovent Biologics' IBI343 as a monotherapy treatment for CLDN18.2-positive PDAC ...

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...

Whether you need to replace lost income or you want to supplement your existing salary, here's how to earn extra money.

Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic macular oedema (DMO) treatment.

From mergers and acquisitions to investing in digital technology, Just Style reveals the trends the fashion industry should ...

A California man named Uriel Gamboa told authorities that he killed his girlfriend Aliya Pitts on Monday, Jan. 6, He ...

Clothing sales bucked a retail sales slowdown in December and retailers are being urged to start adapting to changing market ...

A man accused of sexually assaulting a Pennsylvania college student in 2013 and later sending her a Facebook message ...

Belgium's anti-trust watchdog has started a formal investigation into the domestic market practices of Budweiser and Corona ...